SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

FDMT.O (FDMT.O) News

Track canonical SquawkNews coverage tagged to FDMT.O, FDMT.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol FDMT.O Asset market Sector Markets 90 days 1 Updated Sep 28, 2026, 12:11 PM UTC Open live news feed
M 4D Molecular Therapeutics enrolls first patients in Phase 3 4SIGHT trial of 4D-150 for DME The global Phase 3 study is in treatment-naïve diabetic macular edema. The company also cited updated two-year SPECTRA results supporting durable vision and anatomical improvements. EQUITY | Sep 28, 2026, 12:11 PM UTC